American Biogenetic Sciences researches and develops diagnostic tests for cardiac conditions and infectious diseases, as well as new treatments for neurological disorders including epilepsy, migraine, mania, Parkinson's, male impotence treatment and Alzheimer's disease. ABS also seeks out new technologies and conducts research and development throughout its Global Scientific Network, in the U.S., Europe, Israel, Russia and China. The company's enabling technology includes a patented Antigen-Free mouse colony which allows for the generation of highly specific monoclonal antibodies (Mabs), not acquirable from conventional systems.


American Biogenetic Sciences, Inc. ©2000